Covered recipient · General Payments record
RACHEL EKPENYONG
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2023
$851.52
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $496.48 | 24 |
| Education | $46.35 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $167.00 | 7 |
| Lilly USA, LLC | $104.63 | 7 |
| Janssen Pharmaceuticals, Inc | $74.34 | 3 |
| ALK-Abello, Inc | $47.46 | 2 |
| Acerta Pharma LLC | $46.35 | 1 |
| GlaxoSmithKline, LLC. | $41.23 | 2 |
| Merck Sharp & Dohme Corporation | $24.48 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.72 | 1 |
| Novo Nordisk AS | $14.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.30 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003895317 | CMS |
| ABBVIE INC. | $18.96 | 09/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003895325 | CMS |
| ABBVIE INC. | $22.44 | 10/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003895333 | CMS |
| ABBVIE INC. | $25.30 | 10/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003895341 | CMS |
| ABBVIE INC. | $23.10 | 11/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003895349 | CMS |
| ABBVIE INC. | $34.36 | 11/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003895357 | CMS |
| ABBVIE INC. | $28.54 | 12/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003895365 | CMS |
| ALK-Abello, Inc | $24.70 | 08/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1017124781 | CMS |
| ALK-Abello, Inc | $22.76 | 08/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1017124777 | CMS |
| AstraZeneca Pharmaceuticals LP | $46.35 | 03/27/2023 | Education | Undisputed | 01/23/2026 | 1015652177 | CMS |
| GlaxoSmithKline, LLC. | $20.50 | 08/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004226987 | CMS |
| GlaxoSmithKline, LLC. | $20.73 | 11/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004226979 | CMS |
| Janssen Pharmaceuticals, Inc | $32.83 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987758041 | CMS |
| Janssen Pharmaceuticals, Inc | $25.98 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987758045 | CMS |
| Janssen Pharmaceuticals, Inc | $15.53 | 06/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987758037 | CMS |
| Lilly USA, LLC | $18.90 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033549441 | CMS |
| Lilly USA, LLC | $13.11 | 05/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033192109 | CMS |
| Lilly USA, LLC | $14.09 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033311707 | CMS |
| Lilly USA, LLC | $17.83 | 08/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033475987 | CMS |
| Lilly USA, LLC | $12.96 | 09/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033549435 | CMS |
| Lilly USA, LLC | $13.04 | 10/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033307759 | CMS |
| Lilly USA, LLC | $14.70 | 11/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033307769 | CMS |
| Merck Sharp & Dohme LLC | $24.48 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048513823 | CMS |
| Novartis Pharmaceuticals Corporation | $22.72 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 991544401 | CMS |
| Novo Nordisk Inc | $14.62 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002038041 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.